Putnam Investments LLC Pacira Bio Sciences, Inc. Transaction History

Putnam Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $517,319 - $594,553	-10,096 Reduced 11.76%	75,767 $4.03 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $984,540 - $1.56 Million	19,121 Added 28.65%	85,863 $5.01 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $4.01 Million - $5.11 Million	66,742 New	66,742 $5.09 Million
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $12.8 Million - $18.5 Million	-464,039 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $5.16 Million - $7.98 Million	-172,149 Reduced 27.06%	464,039 $14.5 Million
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $314,550 - $463,678	-9,876 Reduced 1.53%	636,188 $29 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $23.1 Million - $25.5 Million	646,064	646,064 $24.3 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.